Instructions for Omez (omeprazole) capsules
Release Form
caps. enteric soluble 10 mg: 10 or 30 pcs.
Description Omez
The capsules are intestinal soluble, solid gelatin, opaque, size No. 3, with a yellow case, a light violet lid and black "OMEZ 10" marking on the lid and case of the capsule; the contents of the capsules are granules from almost white to light yellow.
1 caps.
omeprazole 10 mg
Auxiliary substances: mannitol - 59 mg, crospovidone - 4.5 mg, poloxamer (407) - 1.25 mg, hypromellose (1828) - 2 mg, meglumin - 0.75 mg.
Coating composition: povidone (K-30) - 6.7 mg.
The composition of the intestinal soluble coating: the copolymer of methacrylic acid and ethyl acrylate [1:1] (the copolymer of methacrylic acid [type C]) - 18 mg, triethyl acetate - 1.8 mg, magnesium stearate - 1 mg.
The composition of the capsule body: iron oxide yellow (E172), titanium dioxide (E171), sodium lauryl sulfate, water, gelatin.
Capsule lid composition: diamond blue dye (E133), sunset yellow dye (E110), red charming dye (E129), floxin B dye (red D&C RED#28), titanium dioxide (E171), sodium lauryl sulfate, water, gelatin.
The composition of the inscription black on capsules: S-1-8114 ink: shellac (20% esterified) in ethanol, iron oxide black dye (E172), n-butanol, propylene glycol (E1520), indigocarmine dye (E132), red charming dye (E129), quinoline yellow dye (E104), diamond blue dye (E133) Ink S-1-8115: shellac (20% esterified) in ethanol, iron oxide black (E172), ethanol, methanol, indigocarmine (E132), red charming (E129), quinoline yellow (E104), diamond blue (E133).
10 pcs - blisters (1) - cardboard packs.
10 pcs - blisters (3) - cardboard packs.
ATX codes
A02BC01 Omeprazole
Clinical and pharmacological groups / Group affiliation
An H<SUP>+</SUP>-K<SUP>+</SUP>-ATP-ase inhibitor. Antiulcer drug
Active ingredient
omeprazole
Pharmacotherapeutic group
Gastric gland secretion reducing agent - proton pump inhibitor
Retention conditions
The drug should be stored in a dry place out of reach for children at a temperature not exceeding 25 °C.
Expiration date
Shelf life is 3 years.
Testimony Omez
Gastresophageal reflux manifestations, such as burning sensations in the stomach and acid spilling from the esophagus
Adults:
· ulceration of the gastric mucosa and duodenum (therapy and prevention);
· eradication of helicobacter pylori for ulcers of the stomach and duodenum (as part of a comprehensive treatment);
· Gastric and duodenal ulcers and erosions associated with NSAIDs (therapy and prevention);
· Inflammation of the esophagus; symptomatic gastresophageal reflux (GERD);
· digestive problems due to the increased acidity of the stomach;
· Zollinger-Ellison disease.
children older than 2 years:
· Esophageal inflammation, Burning and acid miscarriage symptomatic therapy for GERD in children over 2 years of age and > 20 kg;
for children over 4 years:
· eradication of helicobacter pylori in duodenal ulcer (as part of a comprehensive treatment).
method of use, mode and dosage Omez
inside. capsules are usually taken in the morning, preferably half an hour before meals, swallow whole, drinking half a glass of water.
the recommended dose of Omez® is 20 mg (2 capsules) once a day. it is possible to tailor the dosage to achieve a therapeutic effect at a daily dose of 10 mg.
- Nosology (ICD codes)
- B98.0
- Helicobacter pylori as a cause of diseases classified elsewhere
- D44.8
- Involvement of more than one endocrine gland (multiple endocrine adenomatosis)
- E16.4
- Disorders of gastrin secretion (hypergastrinemia, Zollinger-Ellison syndrome)
- E16.8
- Other specified disorders of internal pancreatic secretion
- J95.4
- Mendelssohn's syndrome
- K21.0
- Gastresophageal reflux with esophagitis
- K25
- Gastric ulcer
- K26
- Duodenal ulcer
- K27
- Peptic ulcer
- Y45
- Analgesic, antipyretic, and anti-inflammatory drugs
